Warren Sherman MD

PubMed

• 75 citations
  Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of ran...
  Timothy D. Henry, Douglas W. Losordo, Jay H. Traverse, Richard A. Schatz, E. Marc Jolicoeur
  European Heart Journal. 2018-06-14
• 17 citations
  Independent academic Data Monitoring Committees for clinical trials in cardiovascular and cardiometabolic diseases
  Gerasimos Filippatos, Pieter A. de Graeff, Jeroen J. Bax, John Joseph Borg, John G.F. Cleland
  European Journal of Heart Failure. 2017-04-01
• Multivessel spontaneous coronary artery dissection with angiographic documentation before and after the acute event.
  Mitsuaki Matsumura, Gary S. Mintz, Philip Green, Khady Fall, Warren Sherman
  Coronary Artery Disease. 2015-06-01

Journal Articles

• An open-label dose escalation study to evaluate the safety of administration of nonviral stromal cell-derived factor-1 plasmid to treat symptomatic ischemic heart failure  
  Penn MS, Mendelsohn FO, Schaer GL, Sherman W, Farr M, Pastore J, Rouy D, Clemens R, Aras R, Losordo DW, Circulation Research, 1/1/2012
• Adventitial Delivery of an Allogeneic Bone Marrow Derived Stem Cell in AMI – Phase I Clinical Study  
  Penn MS, Ellis W, Greenbaum A, Hodes Z, Gandhi S, Mendelsohn FO, Strasser D, Ting AE, Sherman W, Circulation Research, 1/1/2012
• Catheter-Based Endomyocardial Delivery of Mesenchymal Precursor Cells Using 3D Echo Guidance Improves Cardiac Function in a Chronic Myocardial Injury Ovine Model  
  Cheng Y, Yi G, Conditt GB, Sheehy A, Kolodgie FD, Tellez A, Polyakov I, Gu A, Aboodi MS, Wallace-Bradley D, Schuster M, Martens T, Kaluza G, Basu S, Virmani R, Granada..., Cell Transplant, 1/1/2012
• Commercialization of trials for peripheral artery disease  
  Sherman W, Mazouz C, Deans R, Patel A, Cytotherapy, 1/1/2011
• A Double-blind, Randomized, Controlled, Multicenter Study to Assess the Safety and Cardiovascular Effects of Skeletal Myoblast Implantation by Catheter Delivery in Pat...  
  Povsic, TJ, O’Connor C M, Henry R, Taussig A, Kereiakes DJ, Fortuin DF, Niederman A, Schatz R, Spencer R, Owens D, Banks M, Joseph D, Roberts R, Alexander JH, Sherman W, Am J Cardiol, 1/1/2011
• Dual catheter technique for the treatment of severe coronary artery perforations  
  Ben-Gal Y, Weisz G, Collins MB, Genereux P, Dangas GD, Teirstein P. S, Singh VP, Rabbani LE, Kodali SK, Sherman W, Leon MB, Moses JW, Catheter Cardiovasc Interv, 1/1/2010
• Determinants of CREB degradation and KChIP2 gene transcription in cardiac memory  
  Ozgen N, Lau DH, Shlapakova IN, Sherman W, Feinmark SJ, Danilo P, Rosen MR, Heart Rhythm, 1/1/2010
• Delivery of biologics in cardiovascular regenerative medicine  
  Bartunek J, Sherman W, Vanderheyden M, Fernandez-Aviles F, Wijns W, Terzic A, Clin Pharmacol Ther, 1/1/2009
• Takotsubo syndrome in a patient undergoing ECT  
  Kent L, Weston C, Heyer C, Sherman W, Prudic J, Am J of Psychiatry, 1/1/2009
• Transcatheter injection-induced changes in human bone marrow-derived mesenchymal stem cells  
  Heng BC, Hsu SH, Cowan CM, Liu A, Tai J, Chan Y, Sherman W, Basu S, Cell Transplant, 1/1/2009
• Myoblast-transfer in an ischemic model of heart failure: effects on rhythm stability  
  Sherman W, He K, Yi G, Harvey J, Lee MJ, Haimes H, Lee P, Wang J, Burkhoff B, Cell Transplant, 1/1/2009
• A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (Prochymal™) following acute myocardial infarction  
  Hare J, Traverse J, Henry T, Dib N, Strumpf R, Schulman S, Gerstenblith G, DeMaria A, Denktas A, Gammon R, Hermiller J, Reisman M, Schaer G, Sherman W, J Am Coll Cardiol, 1/1/2009
• Cardiovascular repair and regeneration 2008: the fourth International Conference on Cell Therapy for Cardiovascular Disease  
  Sherman W, Dimmeler S, Hare JM, Penn M, EuroIntervention, 1/1/2008
• Reducing medical waste (Letter)  
  Sherman W, JAMA, 1/1/2007
• Percutaneous Cell Delivery Techniques: Devices and Issues  
  Sherman W, Martens TP, Ketner W, Siminiak T, EuroIntervention, 1/1/2007
• Burning questions in heart failure management: why do surgeons and interventional cardiologists talk of regenerative cell therapy?  
  Sherman W, Cho C, Martens TP, Heart Fail Clin, 1/1/2007
• Cardiac stem cell therapy from bench to bedside  
  Patel AN, Sherman, W, Cell Transplant, 1/1/2007
• Myocyte replacement therapy: skeletal myoblasts  
  Sherman W, Cell Transplant, 1/1/2007
• Catheter-based delivery of cells to the heart  
  Sherman W, Martens TP, Viles-Gonzalez JF, Siminiak T, Nat Clin Pract Cardiovasc Med, 1/1/2006
• Balloon valvuloplasty and rotational atherectomy stenting in a 92-year-old patient with severe aortic stenosis and unprotected, critical left main disease  
  Doshi, SN., Sherman, W, International Journal of Cardiology, 1/1/2005
• Autologous skeletal myoblast transplantation improved hemodynamics and left ventricular function in chronic heart failure dogs  
  He KL, Yi GH, Sherman W, Zhou H, Zhang GP, Gu A, Kao R, Haimes HB, Harvey J, Roos E, White D, Taylor DA, Wang J, Burkhoff D, J Heart Lung Transplant, 1/1/2005
• Transatrial septal catheterization using a new radiofrequency probe  
  Sherman W, Lee P, Hartley A, Love B, Catheter Cardiovasc Interv, 1/1/2005
• Real time magnetic resonance guided endomyocardial local delivery  
  Corti R, Badimon J, Mizsei G, Macaluso F, Lee, M, Licato P, Viles-Gonzalez J, Fuster V, Sherman W, Heart, 1/1/2005
• Effect of diabetes on long- term mortality following contemporary percutaneous coronary intervention: analysis of 4,284 cases  
  Wilson SR, Valkili BA, Sherman W, Sanborn TA, Brown DL, Diabetes Care, 5/1/2004
• Comparison of three-year outcomes in blacks versus whites with coronary heart disease following percutaneous coronary intervention  
  Berger JS, Sanborn TA, Sherman W, Brown DL, Am J Cardiol, 1/1/2004
• Join now to see all